Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health Canada
Toronto, Canada (ots/PRNewswire) - Archimed, the woundcare division of Insense Ltd., today announced it has received approval from Health Canada for the use of its revolutionary Oxyzyme product in the treatment of difficult and chronic wounds. Oxyzyme was first trialed in Toronto by Dr. Gary Sibbald, one of the world's leading wound care specialists, in 2004 by ...
mehr